Phacilitate Leaders Forum

Phacilitate Leaders Europe Agenda 2018


DEBATE: Building your own cell therapy manufacturing facility Vs. outsourcing the process to partners

Manufacturing Scalability - Cell & Gene Therapy Europe
  • Debate including a case study from each side. Audience questions are encouraged. There will be a vote and a prize for the winning side!
  • Which is the best path to commercial scale? Real life stories from people who have their own facility Vs. people who have outsourced.
  • Is there a middle ground? What to learn from outsourcing parts of your process, where do you invest and who do you bring in as partners?
  • Do CMOs have the ability to work at global scale?
Stephane Boissel, CEO - TxCell
Andreas Schmiede, Head of CDMO Business Unit - apceth Biopharma
Christin Tischner, Project Lead Facility Development and Process Engineering - Cellex GmbH
Danielle M.J. Curfs, CEO and Co-Founder - Medace
Helen Tayton-Martin, COO - Adaptimmune
Marcos Langtry, Outsourced Manufacturing and Development Director - TiGenix
Peter Olagunju, Vice President Patient Operations and LentiGlobin Program Leader - bluebird bio
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd